CAS 2097104-58-8

Spesolimab

CAS: 2097104-58-8

Spesolimab (BI 655130) is an antibody targeting IL-36 receptor, key in immunity, for systemic pustular psoriasis and dermatitis studies.

Pureza: > 95%

Cor e Forma: Liquid

Peso molecular: 150 kDa

Ref: TM-T76884

Spesolimab

CAS: 2097104-58-8

Whole humanized monoclonal antibody targeting Interleukin 36 receptor (IL1RL2/IL1RAP); treatment of generalized pustular psoriasis

Ref: 3D-CLA1541